Vital Clinical Insights and Analytics

for Experts from Experts

Arlington Medical Resources (AMR) is the premier provider of medical data from hospitals and other health care facilities throughout the United States and Europe. Learn More

AREAS OF EXPERTISE

Hospital Therapeutic Audits

AMR provides comprehensive audits of clinical patient data in different therapeutic areas like Anti-infectives, Cardiovascular products, Plasma Expanders and Immunoglobulin products in the hospital setting ...
Learn More

Diagnostic Imaging

AMR produces the Imaging Market Guide, a syndicated audit of diagnostic imaging procedure volumes and contrast media usage. The audit covers conventional x-ray, CT scanning, MRI, ultrasound, nuclear medicine and cardiac cath lab procedure volumes, with iodinated contrast agent and radiopharmaceutical usage information in hospital and non-hospital settings ...
Learn More

Hospital Market Research Updates

Register below to receive our monthly update.

First Name:
Last Name:
Title:
Company:
Email:

  I have read and agree to abide by the Arlington Medical Resources Terms of Use and Privacy Policy.

Click here to read our latest issue.


Global Anti-Infective Markets

Are you positioning your anti-infective product for hospital Pharmacy and Therapeutics committee approval?
 

Get the answers you need to compete in global anti-infective markets

Featured Studies

  • Hospital Insight Series: Nosocomial Pneumonia
    Nosocomial pneumonia is an important segment of the hospital antibiotics market because of the high morbidity and mortality of this infection, limited treatment options, and the increasing incidence of multidrug-resistant pathogens ...
  • Hospital Insight Series: Hospital Anti-Infectives
    The hospital anti-infectives market is a high-value segment of the overall antibacterial market, due, in part, to a variety of unmet needs, the increasing prevalence of drug-resistant pathogens, and the routine use ...
  • Hospital Insight Series: Clostridium Difficile Infections
    With limited therapeutic options available and increasing reports of treatment failures, interviewed thought leaders and physicians alike highlight the need for new, more-effective CDI therapies
Decision Resources Group brands include: